Uscom Akcija

Uscom EBITDA

Vrijednost EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Uscom (UCM.AX) na dan 6. авг 2026. je -2,93 М AUD. Prethodne godine, EBITDA (Заработак пре камата, пореза, амортизације и отписивања) je bio -1,94 М AUD — promjena od 50,99% (niži).

EBITDA

-2,93 МAUD

YoY

50,99%

Zadnja ažuriranja:

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Uscom je 2026 -2,93 М AUD. EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Uscom je bio 2025 -1,94 М AUD. Pad je time 50,99% niži u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

Uscom Анализа акција

Šta radi Uscom? Uscom Ltd is an Australian company that was founded in 2000. The company focuses on the development, manufacturing, and marketing of medical equipment and devices, with a focus on cardiovascular diagnostics. The company is headquartered in Sydney, Australia, and has branches in Europe, North America, and Asia. Uscom consists of a team of experienced scientists, engineers, and medical professionals who collaborate to manufacture and offer high-quality products that are recognized in the medical field worldwide. Uscom's business model is to develop innovative devices that help doctors and medical professionals diagnose and treat their patients more effectively. Over the years, the company has diversified its portfolio and now offers a variety of products that can be classified into different categories. One of Uscom's main divisions is the manufacturing of ultrasound devices that can be used to measure blood flow, blood pressure, and other important cardiovascular parameters. These devices are particularly useful in the diagnosis and monitoring of patients with cardiovascular diseases such as hypertension, heart failure, and stroke. Uscom also offers a range of devices specifically designed for use in intensive care units and emergency rooms. These devices include non-invasive blood pressure monitors, ventilators, and monitoring systems that enable quick and accurate patient monitoring. These devices are used by medical professionals worldwide to save lives and improve the treatment of critical illnesses. In addition to medical devices, Uscom also provides a variety of training and continuing education programs for medical professionals. These trainings include courses on device usage as well as general trainings on cardiovascular health and diagnosis. In recent years, Uscom has specialized in the development and marketing of telemedicine solutions. These solutions allow doctors and patients to communicate and exchange information remotely. This is particularly useful in providing care to patients in remote areas and in other situations where access to medical professionals is limited. One of Uscom's latest developments is a portable ultrasound Doppler device that can be used to measure blood flow, stroke volume, and other important cardiovascular parameters. This device is lightweight and easy to use, enabling doctors to diagnose patients quickly and accurately in any clinical setting. Overall, Uscom has established a good reputation in the medical industry and is considered a leading company in cardiovascular diagnostics. The company continues its efforts to develop innovative products and solutions that can improve the lives of patients worldwide. Uscom je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji Uscom

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) kompanije Uscom iznosi -2,93 М AUD u 2026. godini.

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od Uscom se promijenio sa -1,94 М AUD na -2,93 М AUD, što predstavlja promjenu od 50,99%. Vrijednost je niži nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj EBITDA (Заработак пре камата, пореза, амортизације и отписивања) Uscom od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

EBITDA мери оперативну перформансу пре утицаја финансијске структуре, окружења пореза и не-готовинских отписивања.

EBITDA = EBIT + Амортизација и отписивање

EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s AUD je ključan faktor za investitore. Promene u ovoj metrici mogu signalizirati poboljšane ili pogoršane fundamentalne faktore, direktno utiču na cenu akcije. Na Eulopoolu, možete pratiti EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s Uscom istorijski i u realnom vremenu.

Access this data via the Eulerpool API

Извештај о добити и губитку — Uscom

Sve ključne metrike — Uscom

Раст